The existence and market status of generic drugs of selinesol

Selinexor (Selinexor), a drug targeting relapsed or refractory multiple myeloma (R/R MM) and relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL), has been launched in many overseas countries and has become an important treatment option. However, the high price of original drugs prohibits many patients from taking them. Against this background, generic selinexol emerged as the times require, providing patients with a more economical treatment option.

Currently, several pharmaceutical manufacturers have launched generic versions of selinesol on the market, such as Laos Lucius Pharmaceutical Factory, Daxiong Pharmaceutical Factory, etc. These generic drugs are basically the same as the original drugs in terms of drug ingredients, but there are certain differences in production specifications and prices. In terms of specifications, common generic drug specifications include 20 mg 32 tablets, 20 mg 16 tablets, etc. In terms of price, generic drugs are usually significantly lower than the original drugs, and the price per box may be in the range of 2,000 to 5,000 yuan (the price may fluctuate due to exchange rates).

Selinesol has demonstrated significant therapeutic effects in clinical trials. In the STORM study in patients with refractory multiple myeloma, the combination of seliniso and dexamethasone achieved an overall response rate of 26.2%. In addition, combined application with other drugs also shows good synergy. These research results provide strong support for the wide application of Seleniso in domestic and foreign markets.

For patients, caution is still required when choosing a generic version of selinesol. Although generic drugs are similar in ingredients to original drugs, there may be differences in production processes, quality control, etc. Therefore, patients should choose formal channels when purchasing and use it under the guidance of a doctor.